Gene · 4900
Papers2,084
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,084
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring the Association Between Serum Neurogranin, Nardilysin, and Ischemic Stroke: A Case-Control Study Conducted in the Emergency Department. | Med Sci Monit | 2025 | 40108794 | PubTator, text mining | PubMed |
| Older more fit KL-VS heterozygotes have more favorable AD-relevant biomarker profiles. | medRxiv | 2025 | 40093256 | PubTator, text mining | PubMed |
| Novel plasma biomarkers of amyloid plaque pathology and cortical thickness: Evaluation of the NULISA targeted proteomic platform in an ethnically diverse cohort. | Alzheimers Dement | 2025 | 39989429 | PubTator, text mining | PubMed |
| Biofluid biomarker changes following treatment with sabirnetug (ACU193) in INTERCEPT-AD, a phase 1 trial in early Alzheimer's disease. | J Prev Alzheimers Dis | 2025 | 39955261 | PubTator, text mining | PubMed |
| Corrigendum to "Neurogranin binds alpha-synuclein in the human superior temporal cortex and interaction is decreased in Parkinson's disease" [Brain Res. 1591 (2014) 102-110]. | Brain Res | 2025 | 39947974 | PubTator, text mining | PubMed |
| Changes in molecular biomarkers of neurotoxicity in newborns following prenatal exposure to organophosphate compounds. | Chemosphere | 2025 | 39938320 | PubTator, text mining | PubMed |
| Biomarker treatment effects in two phase 3 trials of gantenerumab. | Alzheimers Dement | 2025 | 39887500 | PubTator, text mining | PubMed |
| Unraveling the inflammation-degeneration tangle in early MS: preliminary insights from ferritin, neurogranin, TREM2, and retinal ganglion cell layer. | J Neurol | 2025 | 39812684 | PubTator, text mining | PubMed |
| Humanin alone and in combination with GnRHa therapy attenuates ovarian dysfunction induced by prepubertal cyclophosphamide chemotherapy in female mice. | Reprod Toxicol | 2025 | 39793741 | PubTator, text mining | PubMed |
| Lecanemab-Associated Amyloid-β Protofibril in Cerebrospinal Fluid Correlates with Biomarkers of Neurodegeneration in Alzheimer's Disease. | Ann Neurol | 2025 | 39761671 | PubTator, text mining | PubMed |
| Addressing inter individual variability in CSF levels of brain derived proteins across neurodegenerative diseases. | Sci Rep | 2025 | 39753643 | PubTator, text mining | PubMed |
| Selenium promotes neural development through the regulation of GPX4 and SEPP1 in an iPSC-derived neuronal model. | Biomaterials | 2025 | 39708777 | PubTator, text mining | PubMed |
| Biomarkers of synaptic degeneration in Alzheimer's disease. | Ageing Res Rev | 2025 | 39701184 | PubTator, text mining | PubMed |
| Plasmodium knowlesi Infection Is Associated With Elevated Circulating Biomarkers of Brain Injury and Endothelial Activation. | J Infect Dis | 2025 | 39658124 | PubTator, text mining | PubMed |
| High CSF neurogranin level is related to lifetime reports of passive suicidal ideation in a population-based sample of older adults. | J Psychiatr Res | 2025 | 39642472 | PubTator, text mining | PubMed |
| Mitochondrial metabolism and redox signaling. | Redox Biol | 2025 | 39632194 | PubTator, text mining | PubMed |
| HDAC4 Inhibits NMDA Receptor-mediated Stimulation of Neurogranin Expression. | Mol Neurobiol | 2025 | 39581920 | PubTator, text mining | PubMed |
| Neuroinflammation in Parkinson's disease: A study with [11C]PBR28 PET and cerebrospinal fluid markers. | Parkinsonism Relat Disord | 2025 | 39531949 | PubTator, text mining | PubMed |
| Endothelial Neurogranin Regulates Blood-Brain Barrier Permeability via Modulation of the AKT Pathway. | Mol Neurobiol | 2025 | 39367201 | PubTator, text mining | PubMed |
| Identifying condition-related cell-cell communication events using supervised tensor analysis. | bioRxiv | 2025 | 38168391 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4900/papers?page=6